Conduit Pharma Gains Nasdaq Capital Market Approval, Transfer Effective May 23
22/5 21:41
(RTTNews) - Conduit Pharmaceuticals Inc. (CDT), a clinical-stage life sciences firm, announced that it has received formal approval from The Nasdaq Stock Market LLC to transfer its common stock listing to The Nasdaq Capital Market....